ENDRA Life Sciences Inc. (NDRA) News
Filter NDRA News Items
NDRA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest NDRA News From Around the Web
Below are the latest news stories about ENDRA LIFE SCIENCES INC that investors may wish to consider to help them evaluate NDRA as an investment opportunity.
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System TechnologyANN ARBOR, Mich., November 29, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued to ENDRA a new patent, U.S. Patent No. 11828727 (the ‘727 patent) titled "Thermoacoustic Probe." |
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor ConferenceANN ARBOR, Mich., November 27, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will be participating in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference being held Thursday, December 7, 2023 at the New York Athletic Club in New York City. Management will be holding one-on-one meetings with investors. |
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call TranscriptENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference […] |
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateANN ARBOR, Mich., November 14, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three and nine months ended September 30, 2023 and provides a business update. Highlights from the third quarter of 2023 and recent weeks include: |
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New PatentsANN ARBOR, Mich., November 08, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of three new patents, including one in the U.S. and two in China. ENDRA’s intellectual property (IP) portfolio now includes 70 issued patents worldwide, enhancing the IP protection for the novel TAEUS® system. |
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023ANN ARBOR, Mich., November 07, 2023--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three and nine months ended September 30, 2023 on Tuesday, November 14, 2023 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate |
ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023ANN ARBOR, Mich., November 06, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced it will host an offsite panel discussion with multidisciplinary experts during the American Association for the Study of Liver Diseases (AASLD) annual meeting, The Liver Meeting, taking place November 10-14, 2023, in Boston. The panel will feature three key opinion leaders (KOLs) in the fields of hepatology, endocrinology and radiology sharing t |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! |
Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023ANN ARBOR, Mich., September 07, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced the acceptance of a clinical abstract titled "Thermoacoustic assessment of fatty liver disease - a clinical feasibility study" for presentation at the Steatotic Liver Disease Summit™ 2023 hosted by the European Association for the Study of the Liver (EASL), taking place September 21-23 in Prague, Czechoslovakia. |
ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDAANN ARBOR, Mich., August 30, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the Company's De Novo request for the TAEUS liver system has advanced to substantive review with the U.S. Food and Drug Administration (FDA). The TAEUS system is ENDRA’s proprietary device that is intended to offer clinicians a tool for the non-invasive assessment of fatty liver tissue, as an aid in the management of patien |